Literature DB >> 29396060

Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma.

Masahide Matsuda1, Hidehiro Kohzuki1, Eiichi Ishikawa1, Tetsuya Yamamoto1, Hiroyoshi Akutsu1, Shingo Takano1, Masashi Mizumoto2, Koji Tsuboi2, Akira Matsumura3.   

Abstract

Despite cumulative evidence supporting the idea that gross total resection (GTR) contributes to prolonged survival of patients with glioblastoma (GBM), the survival outcome of such patients remains unsatisfactory. To develop more effective postoperative therapeutic strategies for patients who underwent GTR, identification of prognostic factors influencing survival is urgently needed. Here we retrospectively analyzed prognostic factors for patients who underwent GTR of newly diagnosed GBM, with a particular focus on the influence of the subventricular zone (SVZ) as the tumor location. Forty-eight consecutive patients with newly diagnosed GBM who underwent GTR during the initial operation were investigated. Tumor involvement of the SVZ was significantly associated with overall survival (OS). The SVZ-positive group had a significantly shorter median OS of 12.2 months, compared to 34.9 months for the SVZ-negative group. The occurrence of leptomeningeal dissemination was significantly influenced by tumor involvement of the SVZ, but was not significantly influenced by ventricular opening during surgery. We observed a statistically significant difference in OS according to radiation modality. The median OS was 36.9 months for patients treated with high-dose proton beam therapy, compared with 26.2 months for patients treated with conventional radiotherapy. We demonstrated that tumor involvement of the SVZ was associated with poor survival of patients who underwent GTR of newly diagnosed GBM, suggesting the potential need for therapeutic strategies that specifically target tumors in the SVZ. Further prospective studies to evaluate whether radiotherapy targeting the SVZ improves survival of patients with tumor involvement of the SVZ who had undergone GTR are warranted.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glioblastoma; Gross total resection; Proton beam therapy; Subventricular zone

Mesh:

Substances:

Year:  2018        PMID: 29396060     DOI: 10.1016/j.jocn.2018.01.009

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy.

Authors:  Taiichi Saito; Yoshihiro Muragaki; Takashi Maruyama; Takashi Komori; Masayuki Nitta; Shunsuke Tsuzuki; Atsushi Fukui; Takakazu Kawamata
Journal:  Neurosurg Rev       Date:  2019-11-08       Impact factor: 3.042

Review 2.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

3.  IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model.

Authors:  Shashwat Tripathi; Tito Vivas-Buitrago; Ricardo A Domingo; Gaetano De Biase; Desmond Brown; Oluwaseun O Akinduro; Andres Ramos-Fresnedo; Wendy Sherman; Vivek Gupta; Erik H Middlebrooks; David S Sabsevitz; Alyx B Porter; Joon H Uhm; Bernard R Bendok; Ian Parney; Fredric B Meyer; Kaisorn L Chaichana; Kristin R Swanson; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2021-10-29       Impact factor: 5.408

4.  Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.

Authors:  Tito Vivas-Buitrago; Ricardo A Domingo; Shashwat Tripathi; Gaetano De Biase; Desmond Brown; Oluwaseun O Akinduro; Andres Ramos-Fresnedo; David S Sabsevitz; Bernard R Bendok; Wendy Sherman; Ian F Parney; Mark E Jentoft; Erik H Middlebrooks; Fredric B Meyer; Kaisorn L Chaichana; Alfredo Quinones-Hinojosa
Journal:  J Neurosurg       Date:  2021-06-04       Impact factor: 5.408

5.  Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line.

Authors:  Francesco P Cammarata; Filippo Torrisi; Giusi I Forte; Luigi Minafra; Valentina Bravatà; Pietro Pisciotta; Gaetano Savoca; Marco Calvaruso; Giada Petringa; Giuseppe A P Cirrone; Anna L Fallacara; Laura Maccari; Maurizio Botta; Silvia Schenone; Rosalba Parenti; Giacomo Cuttone; Giorgio Russo
Journal:  Int J Mol Sci       Date:  2019-09-24       Impact factor: 5.923

6.  Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates.

Authors:  Sharon Berendsen; Emma van Bodegraven; Tatjana Seute; Wim G M Spliet; Marjolein Geurts; Jeroen Hendrikse; Laurent Schoysman; Willemijn B Huiszoon; Meri Varkila; Soufyan Rouss; Erica H Bell; Jérôme Kroonen; Arnab Chakravarti; Vincent Bours; Tom J Snijders; Pierre A Robe
Journal:  PLoS One       Date:  2019-10-11       Impact factor: 3.240

7.  Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2).

Authors:  Marica Ferro; Milena Ferro; Gabriella Macchia; Savino Cilla; Milly Buwenge; Alessia Re; Carmela Romano; Mariangela Boccardi; Vincenzo Picardi; Silvia Cammelli; Eleonora Cucci; Samantha Mignogna; Liberato Di Lullo; Vincenzo Valentini; Alessio Giuseppe Morganti; Francesco Deodato
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.